ask="N/A"
ask_size="N/A"
average_daily_volume="1292130"
bid="N/A"
bid_size="N/A"
book_value="-0.1530"
change="+0.0016"
change_from_200_day_moving_average="-0.0040"
change_from_50_day_moving_average="0.0136"
change_from_52_week_high="-1.1283"
change_From_52_week_low="0.2734"
change_in_percent="+0.3477%"
close="0.4617"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6540"
ebitda="-18.11M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="-0.0900"
eps_estimate_next_year="-0.4500"
ex_dividend_date="N/A"
float_shares="48793000"
high="0.4750"
high_52_weeks="1.5900"
last_trade_date="3/1/2017"
last_trade_price="0.4617"
last_trade_size="1138"
last_trade_time="4:02pm"
low="0.4600"
low_52_weeks="0.1883"
market_capitalization="31.27M"
moving_average_200_day="0.4657"
moving_average_50_day="0.4481"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.0000"
open="0.4650"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-0.8555%"
percent_change_from_50_day_moving_average="+3.0242%"
percent_change_from_52_week_high="-70.9623%"
percent_change_from_52_week_low="+145.1938%"
previous_close="0.4601"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="259.6481"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="1.9100"
stock_exchange="ASE"
symbol="BPMX"
volume="237163"
weeks_range_52="0.1883 - 1.5900"
